Dana Lee
Applied StemCell (United States)(US)
Publications by Year
Research Areas
Biochemical and Molecular Research, Lung Cancer Treatments and Mutations, Cancer, Hypoxia, and Metabolism, Cancer therapeutics and mechanisms, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK -Rearranged Lung Cancer(2016)1,131 cited
- → Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition(2016)978 cited
- → Patient-derived models of acquired resistance can identify effective drug combinations for cancer(2014)731 cited
- → Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment(2002)420 cited
- → KRAS G12C NSCLC Models Are Sensitive to Direct Targeting of KRAS in Combination with PI3K Inhibition(2018)257 cited
- → Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient Care(2017)204 cited
- → SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors(2018)200 cited
- → CD36 Is Important for Chylomicron Formation and Secretion and May Mediate Cholesterol Uptake in the Proximal Intestine(2006)194 cited
- → CO2/HCO3−- and Calcium-regulated Soluble Adenylyl Cyclase as a Physiological ATP Sensor(2013)119 cited
- → Complement Activation in Circulation and Central Nervous System after Rituximab (Anti-CD20) Treatment of B-Cell Lymphoma(2001)91 cited